US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.290
  • -0.020-6.45%
Trading Nov 22 09:30 ET
15.91MMarket Cap-165P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.200M--
--2024/Q4-- / 1.596M--
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.200M--
--2024/Q4-- / 1.596M--
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--

Unlock Free Earnings Estimates

Cara Therapeutics Earnings Reports

  • Cara Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:17 ET

  • Cara Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:16 ET

  • Cara Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 16:20 ET

  • Cara Therapeutics | 8-K: Cara Therapeutics Reports First Quarter 2024 Financial Results

    May 13 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data